Sarah S Lewis1, Kristen V Dicks1, Luke F Chen1, Michael P Bolognesi2, Deverick J Anderson1, Daniel J Sexton1, Rebekah W Moehring3. 1. Division of Infectious Diseases, Department of Medicine Duke Infection Control Outreach Network. 2. Department of Orthopaedic Surgery, Duke University Medical Center. 3. Division of Infectious Diseases, Department of Medicine Duke Infection Control Outreach Network Durham Veterans Affairs Medical Center, North Carolina.
Abstract
BACKGROUND: The timing of diagnosis of invasive surgical site infection (SSI) following joint replacement surgery is an important criterion used to determine subsequent medical and surgical management. METHODS: We compared time to diagnosis of invasive SSI following hip vs knee arthroplasty. SSIs were included in the analysis if they occurred within 365 days following procedures performed from 1 January 2007 through 31 December 2011 at 36 community acute care hospitals and 1 ambulatory surgery center in the Duke Infection Control Outreach Network. A Cox regression model was fitted to estimate the association between procedure type and time to diagnosis of SSI, adjusted for age, pathogen virulence, American Society of Anesthesiologists' score, and hospital surgical volume. RESULTS: Six hundred sixty-one invasive SSIs were identified; 401 (61%) occurred following knee arthroplasties. The median time to diagnosis of SSI was 25 days (interquartile range [IQR], 17-48 days) following hip arthroplasty vs 42 days (IQR, 21-114 days) following knee arthroplasty (unadjusted hazard ratio [HR], 1.60; 95% confidence interval [CI], 1.37-1.87; P < .001). Time to diagnosis of invasive SSI remained significantly shorter for hip than for knee arthroplasties after adjusting for age, pathogen virulence, and hospital surgical volume (HR, 1.51; 95% CI, 1.28-1.78; P < .001). CONCLUSIONS: The diagnosis of invasive SSI was delayed following knee arthroplasty compared with hip arthroplasty. We hypothesize that differences in symptom manifestation and disparities in access to care may contribute to the observed differential timing of diagnosis. Our findings have important implications for the management of prosthetic joint infections, because treatment strategies depend on the timing of diagnosis.
BACKGROUND: The timing of diagnosis of invasive surgical site infection (SSI) following joint replacement surgery is an important criterion used to determine subsequent medical and surgical management. METHODS: We compared time to diagnosis of invasive SSI following hip vs knee arthroplasty. SSIs were included in the analysis if they occurred within 365 days following procedures performed from 1 January 2007 through 31 December 2011 at 36 community acute care hospitals and 1 ambulatory surgery center in the Duke Infection Control Outreach Network. A Cox regression model was fitted to estimate the association between procedure type and time to diagnosis of SSI, adjusted for age, pathogen virulence, American Society of Anesthesiologists' score, and hospital surgical volume. RESULTS: Six hundred sixty-one invasive SSIs were identified; 401 (61%) occurred following knee arthroplasties. The median time to diagnosis of SSI was 25 days (interquartile range [IQR], 17-48 days) following hip arthroplasty vs 42 days (IQR, 21-114 days) following knee arthroplasty (unadjusted hazard ratio [HR], 1.60; 95% confidence interval [CI], 1.37-1.87; P < .001). Time to diagnosis of invasive SSI remained significantly shorter for hip than for knee arthroplasties after adjusting for age, pathogen virulence, and hospital surgical volume (HR, 1.51; 95% CI, 1.28-1.78; P < .001). CONCLUSIONS: The diagnosis of invasive SSI was delayed following knee arthroplasty compared with hip arthroplasty. We hypothesize that differences in symptom manifestation and disparities in access to care may contribute to the observed differential timing of diagnosis. Our findings have important implications for the management of prosthetic joint infections, because treatment strategies depend on the timing of diagnosis.
Authors: Benjamin Zmistowski; Camilo Restrepo; Jordan Hess; Darius Adibi; Soltan Cangoz; Javad Parvizi Journal: J Bone Joint Surg Am Date: 2013-10-16 Impact factor: 5.284
Authors: Douglas R Osmon; Elie F Berbari; Anthony R Berendt; Daniel Lew; Werner Zimmerli; James M Steckelberg; Nalini Rao; Arlen Hanssen; Walter R Wilson Journal: Clin Infect Dis Date: 2012-12-06 Impact factor: 9.079
Authors: Kyle G Miletic; Thomas N Taylor; Emily T Martin; Rahul Vaidya; Keith S Kaye Journal: Infect Control Hosp Epidemiol Date: 2013-12-23 Impact factor: 3.254
Authors: Jonas Marschall; Michael A Lane; Susan E Beekmann; Philip M Polgreen; Hilary M Babcock Journal: Int J Antimicrob Agents Date: 2013-01-09 Impact factor: 5.283
Authors: Deverick J Anderson; Matthew G Hartwig; Theodore Pappas; Daniel J Sexton; Zeina A Kanafani; Grace Auten; Keith S Kaye Journal: Ann Surg Date: 2008-02 Impact factor: 12.969
Authors: Kristen V Dicks; Sarah S Lewis; Michael J Durkin; Arthur W Baker; Rebekah W Moehring; Luke F Chen; Daniel J Sexton; Deverick J Anderson Journal: Infect Control Hosp Epidemiol Date: 2014-03-14 Impact factor: 3.254
Authors: Adina Fésüs; Ria Benkő; Mária Matuz; Orsolya Kungler-Gorácz; Márton Á Fésüs; Tamás Bazsó; Zoltán Csernátony; Gábor Kardos Journal: Antibiotics (Basel) Date: 2021-12-09